A bioengineered in situ ovary (ISO) supports follicle engraftment and live-births post-chemotherapy

Female cancer patients who have undergone chemotherapy have an elevated risk of developing ovarian dysfunction and failure. Experimental approaches to treat iatrogenic infertility are evolving rapidly; however, challenges and risks remain that hinder clinical translation. Biomaterials have improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckenmeyer, Michael J, Sukhwani, Meena, Iftikhar, Aimon, Nolfi, Alexis L, Xian, Ziyu, Dadi, Srujan, Case, Zachary W, Steimer, Sarah R, D’Amore, Antonio, Orwig, Kyle E, Brown, Bryan N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656812/
https://www.ncbi.nlm.nih.gov/pubmed/38029018
http://dx.doi.org/10.1177/20417314231197282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656812/
https://www.ncbi.nlm.nih.gov/pubmed/38029018
http://dx.doi.org/10.1177/20417314231197282

Ejemplares similares